Genedx Holdings Corp (WGS) Stock Price, Quote & News

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 888 729 1206

Fax: 201 421 2010

Website: www.genedx.com

Address:

North Tower, 6th Floor 333 Ludlow Street, Stamford, United States

CarverX Jul. 9 at 5:37 PM

$WGS Wants to stay at pre earnings level. Let’s hope stue and uncle fester get their act together 🚀🚀🚀

0 · Reply

History923 Jul. 9 at 4:38 PM

$WGS 🔥🔥‼️

0 · Reply

stocksmit Jul. 9 at 2:41 PM

$WGS beautiful.

0 · Reply

History923 Jul. 9 at 10:34 AM

$WGS Trump Is the biggest manipulator!!. Cheater !!. Ignore this scammer he causes war in the short term to fill pockets again then communicate again via media everything is ok we have No more war. He has to go to jail‼️

0 · Reply

History923 Jul. 8 at 9:48 PM

$WGS Trump is manipulating the market with his war!!. He does it to earn a lot of money and 2 weeks is over again. This man belongs in jail ‼️

0 · Reply

History923 Jul. 8 at 2:24 PM

$WGS Trump is the biggest fraudster who constantly manipulates to increase his and his family’s billions. After 2 weeks can after 2 days reported of peace agreement he looks at .. he has earned well

0 · Reply

History923 Jul. 8 at 9:14 AM

$WGS After 2 weeks is again ceasefire and end of war Trump will always play like this this scammer actually has to ignore market this guy because he is cheating‼️‼️

0 · Reply

History923 Jul. 8 at 6:50 AM

$WGS Trump manipulates the market of his war games and killing people promotes his money to push up. He knows when war comes because he decides for himself so his family and he can easily increase the billions! This is wanted by Him all strategically at the expense of human lives‼️‼️‼️

0 · Reply

History923 Jul. 7 at 8:42 PM

$WGS Every day the same negative message!!.

0 · Reply

History923 Jul. 7 at 7:47 PM

$WGS

0 · Reply

WGS Stockholders Have Rights – If You Lost Money Investing in GeneDx Holdings Corp. Contact Robbins LLP for Information About Recovering Your Losses

2026-06-29T11:05:43.000Z - 10 days ago

GeneDx price target raised to $74 from $70 at Guggenheim

2026-06-23T11:03:08.000Z - 16 days ago

GeneDx price target raised to $63 from $50 at Piper Sandler

Jun 18, 2026, 9:00 AM EDT - 21 days ago

GeneDx Holdings Transcript: AGM 2026

2026-06-16T12:38:10.000Z - 23 days ago

GeneDx appoints Gardner as President

Jun 16, 2026, 8:30 AM EDT - 23 days ago

GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth

Jun 15, 2026, 9:30 AM EDT - 24 days ago

Investor Notice of Barrack, Rodos & Bacine Concerning Its Lawsuit Against GeneDx Holdings Corp. (WGS)

Jun 11, 2026, 9:00 AM EDT - 4 weeks ago

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. Lawsuit - WGS

Jun 10, 2026, 9:47 AM EDT - 4 weeks ago

GENEDX HOLDINGS CORP. (WGS) INVESTOR ALERT Investors With Large Losses in GeneDe Holdings Corp. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jun 10, 2026, 8:27 AM EDT - 4 weeks ago

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of GeneDx Holdings Corp. (WGS)

Jun 9, 2026, 8:00 AM EDT - 4 weeks ago

GeneDx Holdings Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 4, 2026, 3:30 PM EDT - 5 weeks ago

GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS

May 26, 2026, 4:05 PM EDT - 6 weeks ago

GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 20, 2026, 9:30 AM EDT - 7 weeks ago

Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud

2026-05-05T12:38:23.000Z - 2 months ago

GeneDx price target lowered to $85 from $153 at Craig-Hallum

May 5, 2026, 8:09 AM EDT - 2 months ago

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

2026-05-05T12:02:38.000Z - 2 months ago

GeneDx price target lowered to $55 from $60 at TD Cowen

2026-05-05T11:43:37.000Z - 2 months ago

GeneDx price target lowered to $90 from $170 at BTIG, removed from Top Picks

2026-05-05T11:27:49.000Z - 2 months ago

GeneDx price target lowered to $70 from $100 at Guggenheim

2026-05-05T10:25:04.000Z - 2 months ago

GeneDx price target lowered to $75 from $155 at Wells Fargo

2026-05-04T20:32:20.000Z - 2 months ago

GeneDx reports Q1 adjusted loss ($8.2M) vs. ($9.2M) last year

May 4, 2026, 4:30 PM EDT - 2 months ago

GeneDx Holdings Earnings Call Transcript: Q1 2026

May 4, 2026, 4:30 PM EDT - 2 months ago

GeneDx Holdings Slides: Q1 2026

May 4, 2026, 4:30 PM EDT - 2 months ago

GeneDx Holdings Earnings release: Q1 2026

May 4, 2026, 4:30 PM EDT - 2 months ago

GeneDx Holdings Quarterly report: Q1 2026

May 4, 2026, 4:05 PM EDT - 2 months ago

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

Apr 30, 2026, 8:00 AM EDT - 2 months ago

GeneDx Holdings Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

GeneDx Holdings Proxy statement: Proxy filing

2026-04-20T13:59:20.000Z - 2 months ago

GeneDx price target raised to $100 from $70 at Canaccord

Apr 13, 2026, 4:05 PM EDT - 3 months ago

GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026

2026-04-10T04:42:30.000Z - 3 months ago

Cathie Wood Buys the Dip in GeneDx (WGS); Wall Street Sees 142% Upside

ARCT ARKG ARKK BWXT SRTA

2026-03-30T11:51:54.000Z - 3 months ago

GeneDx price target lowered to $100 from $170 at Guggenheim

Mar 11, 2026, 5:00 PM EDT - 4 months ago

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

Mar 11, 2026, 3:00 PM EDT - 4 months ago

GeneDx Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 10, 2026, 8:30 AM EDT - 4 months ago

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

Mar 9, 2026, 8:30 AM EDT - 4 months ago

GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership

Feb 25, 2026, 8:03 PM EST - 4 months ago

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Feb 25, 2026, 8:30 AM EST - 4 months ago

GeneDx to Participate in Upcoming Investor Conferences

Feb 23, 2026, 8:30 AM EST - 4 months ago

GeneDx Holdings Earnings Call Transcript: Q4 2025

Feb 23, 2026, 8:30 AM EST - 4 months ago

GeneDx Holdings Annual report: Q4 2025

Feb 23, 2026, 8:30 AM EST - 4 months ago

GeneDx Holdings Earnings release: Q4 2025

Feb 23, 2026, 8:30 AM EST - 4 months ago

GeneDx Holdings Slides: Q4 2025

Feb 23, 2026, 8:07 AM EST - 4 months ago

INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 23, 2026, 6:30 AM EST - 4 months ago

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 11, 2026, 9:05 AM EST - 5 months ago

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

Feb 3, 2026, 8:00 AM EST - 5 months ago

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

Jan 15, 2026, 11:24 AM EST - 6 months ago

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Jan 14, 2026, 6:00 PM EST - 6 months ago

GeneDx Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:00 PM EST - 6 months ago

GeneDx Holdings Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 3:03 PM EST - 6 months ago

Why is GeneDx stock crashing on Monday?

Jan 12, 2026, 7:30 AM EST - 6 months ago

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

Jan 8, 2026, 8:30 AM EST - 6 months ago

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

Jan 7, 2026, 8:30 AM EST - 6 months ago

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

Jan 6, 2026, 8:30 AM EST - 6 months ago

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

Jan 5, 2026, 8:30 AM EST - 6 months ago

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

Dec 30, 2025, 8:00 AM EST - 6 months ago

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

Dec 15, 2025, 8:30 AM EST - 7 months ago

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Dec 11, 2025, 10:37 AM EST - 7 months ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA PODD UNH

Dec 3, 2025, 1:30 PM EST - 7 months ago

GeneDx Holdings Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 6:00 AM EST - 8 months ago

GeneDx Holdings Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 2:00 PM EST - 8 months ago

GeneDx Holdings Transcript: Stifel 2025 Healthcare Conference

Nov 6, 2025, 8:00 AM EST - 8 months ago

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

Oct 28, 2025, 8:30 AM EDT - 9 months ago

GeneDx Holdings Earnings Call Transcript: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 9 months ago

GeneDx Holdings Quarterly report: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 9 months ago

GeneDx Holdings Earnings release: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 9 months ago

GeneDx Holdings Slides: Q3 2025

Oct 28, 2025, 6:30 AM EDT - 9 months ago

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

CarverX Jul. 9 at 5:37 PM

$WGS Wants to stay at pre earnings level. Let’s hope stue and uncle fester get their act together 🚀🚀🚀

0 · Reply

History923 Jul. 9 at 4:38 PM

$WGS 🔥🔥‼️

0 · Reply

stocksmit Jul. 9 at 2:41 PM

$WGS beautiful.

0 · Reply

History923 Jul. 9 at 10:34 AM

0 · Reply

History923 Jul. 8 at 9:48 PM

$WGS Trump is manipulating the market with his war!!. He does it to earn a lot of money and 2 weeks is over again. This man belongs in jail ‼️

0 · Reply

History923 Jul. 8 at 2:24 PM

0 · Reply

History923 Jul. 8 at 9:14 AM

$WGS After 2 weeks is again ceasefire and end of war Trump will always play like this this scammer actually has to ignore market this guy because he is cheating‼️‼️

0 · Reply

History923 Jul. 8 at 6:50 AM

0 · Reply

History923 Jul. 7 at 8:42 PM

$WGS Every day the same negative message!!.

0 · Reply

History923 Jul. 7 at 7:47 PM

$WGS

0 · Reply

History923 Jul. 7 at 12:27 PM

$WGS 🔥‼️‼️

0 · Reply

11thestate Jul. 6 at 2:00 PM

Don't forget that there is also an important settlement to watch for $SMFR /$WGS We have every detail, including how investors can get paid:https://11th.com/cases/sema4-investor-suit

0 · Reply

Badinvestor50 Jul. 2 at 5:10 PM

$WGS down 5% on 360k in volume what a joke

0 · Reply

CarverX Jul. 1 at 8:11 PM

$WGS $TEM Good moves today in gene diagnostics 🚀🚀🚀

0 · Reply

11thestate Jun. 30 at 2:08 PM

If you missed the deadline, don’t miss this update. This is probably the most useful info you’ve read in years about $WGS how you can actually recover something:https://11th.com/cases/cmls-investor-settlement

0 · Reply

Buckanator Jun. 29 at 6:00 PM

$WGS I sold today at $68.95, Great trade, more than doubled my money.

2 · Reply

CarverX Jun. 29 at 5:04 PM

$WGS Probably 60s range bound til earnings

1 · Reply

Badinvestor50 Jun. 26 at 6:41 PM

$BSX $WGS well I jinxed these two that’s for sure

0 · Reply

Badinvestor50 Jun. 26 at 4:25 PM

$BSX rip missing $45. It’s alright this is going to move back like $WGS soon

0 · Reply

PencilNeckGeek Jun. 26 at 2:17 PM

$WGS Impressive how strong this has been

0 · Reply

CarverX Jun. 25 at 7:47 PM

$WGS Lots of insider purchases to buffet the sp and get the shyster lawyersboff our backs. Time for Stue to step up or time for Meister to get rid of her🚀🚀🚀

0 · Reply

PencilNeckGeek Jun. 25 at 7:26 PM

$WGS Pretty amazing strength this has shown recently

0 · Reply

Market Cap	1.94B
Revenue (ttm)	427.54M
Net Income (ttm)	-21.02M
EPS (ttm)	N/A
PE Ratio	81.05
Forward PE	N/A
Profit Margin	-4.92%
Debt to Equity Ratio	0.38

Volume	623,516
Avg Vol	1,493,302
Day's Range	N/A - N/A
Shares Out	29.69M
Stochastic %K	22%
Beta	1.90
Analysts	Strong Sell
Price Target	$78.89